stockportfolio.pro
Edwards Lifesciences Corporation P/E Ratio 2008–2025
Edwards Lifesciences Corporation (EW) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +8.1%/yr over 17 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 46.58 | +338.6% |
| FY 2024 | 10.62 | -68.0% |
| FY 2023 | 33.15 | +8.4% |
| FY 2022 | 30.58 | -43.8% |
| FY 2021 | 54.43 | -22.4% |
| FY 2020 | 70.18 | +48.0% |
| FY 2019 | 47.42 | +4.9% |
| FY 2018 | 45.18 | +8.2% |
| FY 2017 | 41.74 | +16.3% |
| FY 2016 | 35.90 | +2.3% |
| FY 2015 | 35.10 | +3.1% |
| FY 2014 | 34.06 | +77.1% |
| FY 2013 | 19.23 | -47.5% |
| FY 2012 | 36.65 | +2.7% |
| FY 2011 | 35.71 | -19.2% |
| FY 2010 | 44.17 | +98.4% |
| FY 2009 | 22.27 | +78.3% |
| FY 2008 | 12.49 | — |
Source: Edwards Lifesciences Corporation SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Edwards Lifesciences Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeEdwards Lifesciences Corporation — frequently asked questions
What is Edwards Lifesciences Corporation's price-to-earnings ratio?
Edwards Lifesciences Corporation (EW) reported price-to-earnings ratio of 46.58 for fiscal year 2025, per its SEC filings.
How has Edwards Lifesciences Corporation's price-to-earnings ratio changed over time?
Between fiscal 2008 and 2025, EW's price-to-earnings ratio grew at roughly 8.1% per year (compound annual rate), from 12.49 to 46.58.
Where does this data come from?
Figures are computed from Edwards Lifesciences Corporation's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.